2021-01-28 18:04 Scientists all over the world are actively researching novel coronavirus (also known as SARS-CoV-2) and developing antiviral vaccines and drugs to cope with the global COVID-19 pandemic caused by the virus. Creative Biostructure has extensive experience in solving bioinformatics problems for genomics and proteomics. We currently provide bioinformatics solutions for viral metagenomics to support diagnostics and drug development in the field of coronavirus infection research.